Edwards Lifesciences Corp (EW)
88.61
+0.86
(+0.98%)
USD |
NYSE |
Apr 24, 16:00
87.15
-1.46
(-1.65%)
Pre-Market: 20:00
Edwards Lifesciences Enterprise Value: 52.30B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 52.30B |
| April 23, 2024 | 51.79B |
| April 22, 2024 | 51.31B |
| April 19, 2024 | 50.70B |
| April 18, 2024 | 51.00B |
| April 17, 2024 | 51.48B |
| April 16, 2024 | 53.17B |
| April 15, 2024 | 52.66B |
| April 12, 2024 | 53.31B |
| April 11, 2024 | 53.99B |
| April 10, 2024 | 54.05B |
| April 09, 2024 | 54.97B |
| April 08, 2024 | 54.55B |
| April 05, 2024 | 54.76B |
| April 04, 2024 | 53.86B |
| April 03, 2024 | 54.95B |
| April 02, 2024 | 55.73B |
| April 01, 2024 | 55.69B |
| March 28, 2024 | 56.48B |
| March 27, 2024 | 56.24B |
| March 26, 2024 | 55.20B |
| March 25, 2024 | 55.04B |
| March 22, 2024 | 55.42B |
| March 21, 2024 | 55.95B |
| March 20, 2024 | 54.97B |
| Date | Value |
|---|---|
| March 19, 2024 | 55.73B |
| March 18, 2024 | 54.85B |
| March 15, 2024 | 54.53B |
| March 14, 2024 | 55.16B |
| March 13, 2024 | 54.90B |
| March 12, 2024 | 53.69B |
| March 11, 2024 | 53.64B |
| March 08, 2024 | 54.43B |
| March 07, 2024 | 55.43B |
| March 06, 2024 | 52.13B |
| March 05, 2024 | 50.79B |
| March 04, 2024 | 51.35B |
| March 01, 2024 | 50.26B |
| February 29, 2024 | 50.05B |
| February 28, 2024 | 50.73B |
| February 27, 2024 | 51.04B |
| February 26, 2024 | 50.82B |
| February 23, 2024 | 51.78B |
| February 22, 2024 | 51.71B |
| February 21, 2024 | 51.12B |
| February 20, 2024 | 51.27B |
| February 16, 2024 | 50.79B |
| February 15, 2024 | 50.76B |
| February 14, 2024 | 50.76B |
| February 13, 2024 | 50.89B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
31.68B
Minimum
Mar 23 2020
80.39B
Maximum
Dec 30 2021
52.36B
Average
50.25B
Median
Dec 03 2019
Enterprise Value Benchmarks
| Stryker Corp | 138.03B |
| Boston Scientific Corp | 115.45B |
| Align Technology Inc | 22.59B |
| Abbott Laboratories | 193.10B |
| Steris PLC | 23.17B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 369.90M |
| Revenue (Quarterly) | 1.534B |
| Total Expenses (Quarterly) | 1.106B |
| EPS Diluted (Quarterly) | 0.61 |
| Gross Profit Margin (Quarterly) | 76.74% |
| Profit Margin (Quarterly) | 24.11% |
| Earnings Yield | 2.60% |
| Operating Earnings Yield | 3.20% |
| Normalized Earnings Yield | 2.893 |